Etirinotecan Pegol (NKTR-102) in Third-line Treatment of Patients With Metastatic or Recurrent Non-Small-cell Lung Cancer: Results of a Phase II Study.

Details

Language :

English

ISSN :

15257304

Volume :

19

Issue :

2

Database :

Complementary Index

Journal :

Clinical Lung Cancer

Publication Type :

Academic Journal

Accession number :

128123612

Full Text :

https://doi.org/10.1016/j.cllc.2017.10.007